Incidence and Clinical Characteristics of Genetic Disorders Detected Through Expanded Newborn Screening at Queen Sirikit National Institute of Child Health in Thailand: A 4-Year Retrospective Analysis
International Journal of Neonatal Screening · 19.10.2026 · 12 (4) · 88
DOI: 10.3390/ijns12040088 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 19.10.2026. Verfasst von Chulaluck Kuptanon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Section, Queen Sirikit National Institute of Child Health, Bangkok 10400, Thailand. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Expanded newborn screening (eNBS) using tandem mass spectrometry (MS/MS) optimizes outcomes for inborn errors of metabolism (IEMs). Following Thailand’s universal eNBS rollout, we evaluated the 4-year diagnostic performance, disease spectrum, and operational challenges of a major regional screening center. This retrospective cohort study evaluated 202,305 neonates screened at the Queen Sirikit National Institute of Child Health (2022–2025). The protocol transitioned from an in-house LC-MS/MS assay to a commercial non-derivatized kit featuring succinylacetone quantification. Screening interpretation was optimized using secondary analyte ratios and R4S/CLIR scoring systems. Fifty-five infants were confirmed with an on-panel IEM (birth incidence 1:3678). Median turnaround time was at 7 days of age. The initial screen identified 51 true-positive cases, restricting the program false-positive rate to 0.15%, while eight presumptive positive individuals were lost to follow-up. Three citrullinemia type 2 cases were captured via routine second screening, and one clinical tyrosinemia type 1 case was missed during the early in-house assay phase. The regional hub demonstrated robust diagnostic performance and efficiency within Thailand’s universal healthcare framework. While post-analytical algorithms successfully optimize specificity, the identification of initial false negatives highlights the necessity of repeat screening in vulnerable populations—such as low birth weight or small-for-gestational-age infants—to capture delayed biomarker elevations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Genetics Section, Queen Sirikit National Institute of Child Health, Bangkok 10400, Thailand.
- Department of Pediatrics, College of Medicine, Rangsit University, Bangkok 10400, Thailand.
- Newborn Screening Laboratory, Department of Pathology, Queen Sirikit National Institute of Child Health, Bangkok 10400, Thailand.
Zitieren
APA
Kuptanon, C., Khata, D., Singhamatr, P., Peeramontree, K., & Khontha, S. (2026). Incidence and Clinical Characteristics of Genetic Disorders Detected Through Expanded Newborn Screening at Queen Sirikit National Institute of Child Health in Thailand: A 4-Year Retrospective Analysis. International Journal of Neonatal Screening, 12(4), 88. https://doi.org/10.3390/ijns12040088
Vancouver
Kuptanon C, Khata D, Singhamatr P, Peeramontree K, Khontha S. Incidence and Clinical Characteristics of Genetic Disorders Detected Through Expanded Newborn Screening at Queen Sirikit National Institute of Child Health in Thailand: A 4-Year Retrospective Analysis. International Journal of Neonatal Screening. 2026;12(4):88. doi:10.3390/ijns12040088
BibTeX
@article{Kuptanon2026,
author = {Kuptanon, Chulaluck and Khata, Dueanchai and Singhamatr, Pon and Peeramontree, Kulayaporn and Khontha, Sansanee},
title = {Incidence and Clinical Characteristics of Genetic Disorders Detected Through Expanded Newborn Screening at Queen Sirikit National Institute of Child Health in Thailand: A 4-Year Retrospective Analysis},
journal = {International Journal of Neonatal Screening},
year = {2026},
volume = {12},
number = {4},
pages = {88},
doi = {10.3390/ijns12040088}
}
EUVIMED